AMP-Deoxynojirimycin

CAS No. 216758-20-2

AMP-Deoxynojirimycin( —— )

Catalog No. M34776 CAS No. 216758-20-2

AMP-Deoxynojirimycin (AMP-DNM) is a potent inhibitor of ceramide glucosyltransferase and GCase 2, as well as GlcCer biosynthesis, and is utilized in the study of Parkinson's disease and diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 149 Get Quote
5MG 394 Get Quote
10MG 690 Get Quote
25MG 1003 Get Quote
50MG 1362 Get Quote
100MG 1782 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AMP-Deoxynojirimycin
  • Note
    Research use only, not for human use.
  • Brief Description
    AMP-Deoxynojirimycin (AMP-DNM) is a potent inhibitor of ceramide glucosyltransferase and GCase 2, as well as GlcCer biosynthesis, and is utilized in the study of Parkinson's disease and diabetes.
  • Description
    AMP-Deoxynojirimycin (AMP-DNM) is a potent ceramide glucosyltransferase and GCase 2 inhibitor. AMP-Deoxynojirimycin also is a GlcCer biosynthesis inhibitor.
  • In Vitro
    AMP-Deoxynojirimycin (10 μM) significantly blocks the leucine and C17ISO-induced P70S6K phosphorylation in 3T3-L1 cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Transferase | Glucosidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    216758-20-2
  • Formula Weight
    397.55
  • Molecular Formula
    C22H39NO5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OCCCCCN1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](O)C1)C23CC4CC(C2)CC(C3)C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhu M, et al. Monomethyl branched-chain fatty acid mediates amino acid sensing upstream of mTORC1. Dev Cell. 2021 Oct 11;56(19):2692-2702.e5.?
molnova catalog
related products
  • Hydroprotopine

    Hydroprotopine, treatment for coronary heart disease and angina, and the treatment effect is remarkable.

  • Minodronic acid mono...

    Minodronic acid monohydrate?is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.

  • DGAT1-IN-1

    DGAT1-IN-1 is a potent inhibitor of diacylglycerol O- acyltransferase type 1(DGAT1, IC50 of < 10 nM).